Rana Al-Jumah
Pain Medicine · Seattle, WANPI 1073046959
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,267 of the $4,366 with a category attached, or 74.8%. Abbott accounts for 88.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $3,990 and has fallen 99.4% since, to $24 in 2025.
Across 39 payments — averaging $111.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- AbbVie$167
- Medtronic$119
- Boston Scientific$103
- SPR Therapeutics, Inc$55
- Johnson & Johnson$42
- plus $28 from 1 others
What the payments were for
- Travel & lodging$3,26775%
- Food & beverage$1,09925%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $3,853 |
| AbbVie(2 entities) | 7 | $167 |
| Medtronic | 3 | $119 |
| Boston Scientific | 1 | $103 |
| SPR Therapeutics, Inc | 1 | $55 |
| Johnson & Johnson | 2 | $42 |
| Si-bone, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,554
- PRODIGY$1,069
- INTELLIS ADAPTIVESTIM$110
How this compares
$4,366 in reported general payments places this provider in the 65th percentile of 124 pain medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 21 | $303 |
| Duloxetine Hcl | 16 | $137 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Seattle
- Steven StanosSeattle$206K
- Corrie AndersonSeattle$102K
- Gregory TermanSeattle$95K
- Miroslav BackonjaSeattle$22K
- Alex CahanaSeattle$12K
- Michael GofeldSeattle$8K
- Christopher MerifieldSeattle$5K
- Agnes StogiczaSeattle$5K
- Alexander NguyenSeattle$4K
- Juan Ruiz HurtarteSeattle$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.